Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Asston Pharmaceuticals has informed BSE that its trading window will be closed from 1st April 2026 until 48 hours after the declaration of audited financial results for the quarter and financial year ended 31st March 2026. This is a routine compliance measure under SEBI's Insider Trading Regulations, 2015, restricting directors, KMPs, designated persons, insiders, connected persons, and their immediate relatives from trading in the company's shares during this period. The board meeting date to approve the audited results will be communicated separately. The intimation was signed by Rishi Upadhaya, Company Secretary and Compliance Officer.
This is a standard regulatory filing and does not have a direct impact on shareholders. However, it signals that the company is preparing to announce its annual audited results soon, which may be a key event for investors to watch.